{"id":"folescutol","rwe":[{"pmid":"4560013","year":"1972","title":"[Clinical trial of Folescutol in phlebology].","finding":"","journal":"Bordeaux medical","studyType":"Clinical Study"},{"pmid":"5076842","year":"1972","title":"[Trial prevention of edema by revascularization with folescutol].","finding":"","journal":"Marseille medical","studyType":"Clinical Study"},{"pmid":"5563526","year":"1971","title":"[Clinical and pharmacodynamic study of folescutol or LD 2988].","finding":"","journal":"Phlebologie","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"pholescutol","offLabel":[],"synonyms":["LD 2988","folescutol","pholescutol"],"timeline":[],"approvals":[],"brandName":"Pholescutol","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells have locks on them, and Pholescutol is a key that fits into one of those locks. When it binds, it changes the way the lock works, which can help to treat a particular disease or condition. This is a simplified explanation of how Pholescutol works at a molecular level.","oneSentence":"Pholescutol is a small molecule that binds to a specific target, altering its function to produce a therapeutic effect.","technicalDetail":"Pholescutol's mechanism of action involves binding to a specific protein target, potentially altering its activity or expression, although the exact details of this interaction are unknown."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3750","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FOLESCUTOL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:37:36.687819","biosimilars":[],"competitors":[],"genericName":"folescutol","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"D32TNF4T6G","CHEBI":"CHEBI:135146","INN_ID":"2008","UMLSCUI":"C0304536","ChEMBL_ID":"CHEMBL2104742","PUBCHEM_CID":"5390105","MESH_SUPPLEMENTAL_RECORD_UI":"C002382"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":3,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"1972 Jun","pmid":"4560013","title":"[Clinical trial of Folescutol in phlebology].","journal":"Bordeaux medical"},{"date":"1972","pmid":"5076842","title":"[Trial prevention of edema by revascularization with folescutol].","journal":"Marseille medical"},{"date":"1971 Apr-Jun","pmid":"5563526","title":"[Clinical and pharmacodynamic study of folescutol or LD 2988].","journal":"Phlebologie"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Pholescutol (FOLESCUTOL) is a small molecule modality developed by an unknown entity, currently owned by an unknown entity. Its target and drug class are unknown, and it has not been approved by the FDA for any indications. The commercial status of Pholescutol is unclear, and it is not known whether it is patented or available as a generic. Further information on its pharmacokinetic properties, such as half-life and bioavailability, is also unavailable. As a result, key safety considerations and potential side effects are unknown.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}